To identify high-frequency, low-penetrance breast cancer modifier genes, we have developed a rat genetic model that uses the Wistar-Kyoto (WKy) inbred strain, resistant to developing 7,12-dimethylbenz[a]anthracene-induced mammary carcinogenesis, as a congenic donor and the susceptible Wistar-Furth (WF) strain as the recipient. Here, data from congenic rat lines containing smaller WKy genomic intervals of the Mcs5 quantitative trait locus region are presented to fine map three independently acting Mcs5 subloci. WKyhomozygous females from congenic lines defining Mcs5a, Mcs5b, and Mcs5c averaged, respectively, 4.0 F 0.4, 11.6 F 0.6, and 3.5 F 0.4 mammary carcinomas per rat. These phenotypic values are statistically different from the WF-homozygous phenotype value of 8.0 F 0.4, which is the baseline phenotype used for these experiments. We identified a likely Mcs5a Â Mcs5b epistatic interaction that results in masking the increased susceptibility effect of the Mcs5b WKy allele by the Mcs5a WKy allele. We also provide evidence for a Mcs5a Â Mcs5c interaction that is synergistic to decrease mammary carcinoma susceptibility below the additive effects of WKy alleles at each locus independently. The Mcs5 subloci are currently localized to 1.0, 7.5, and 4.5 Mb of rat chromosome 5, and the orthologous regions are on human chromosome 9 and mouse chromosome 4. These loci will provide unbiased candidate gene loci for evaluation in human case-control association studies. (Cancer Res 2005; 65(21): 9637-42) 
Introduction
Inherited risk of developing breast cancer for most individuals is controlled by an undetermined number of risk alleles. Many of these are expected to have higher population frequency compared with the rare risk alleles of BRCA1 or BRCA2. The collective effect of the low-penetrance breast cancer modifier genes on population risk likely exceeds that of the highly penetrant breast cancer susceptibility alleles, BRCA1 or BRCA2. Estimates indicate that if all the breast cancer risk alleles were known, almost 90% of breast cancer cases could be assigned to 50% of the population of women at highest risk (1) . Understandably, these predictions have generated much interest in identifying breast cancer modifier gene loci. Historically, most work to identify modifier genes has focused on biased selection of candidate gene loci for human association studies. For example, many candidate genes that function in cancerrelated pathways (e.g., DNA repair genes) have been investigated over the last two decades with little progress toward positive association results that were verifiable in large population studies (2) . We are using rodent/human comparative genomics to incorporate an unbiased method of selecting modifier candidate gene loci for human breast cancer case-control association studies. Our study uses the rat mammary carcinogenesis model, which we view as a good model for human breast cancer. Many inbred rat strains are available that vary dramatically in mammary cancer susceptibility. Our studies use congenic rat lines to develop genetic models of breast cancer susceptibility. For the study here, the recipient rat strain providing the base susceptibility phenotype is the WistarFurth (WF), which is highly sensitive to 7,12-dimethylbenz[a]anthracene (DMBA)-induced mammary carcinogenesis. The donor strain, resistant to DMBA-induced mammary carcinogenesis, is the Wistar-Kyoto (WKy) strain. Classic quantitative trait linkage analyses using crosses between the WF and either of two resistant strains have identified a total of eight quantitative trait loci (QTL; refs. 3, 4) . These loci are termed mammary carcinoma susceptibility loci 1 to 8 (Mcs1-Mcs8). We previously reported the confirmation of the QTL that had the highest LOD score in a backcross linkage mapping analysis (4), Mcs5, and defined the locus to a 115-Mb region of chromosome 5 using congenic rat lines (5) . Here, we continue our comparative genomic search for breast cancer modifier genes by fine mapping the Mcs5 locus and identifying multiple subloci within it that modify mammary cancer risk.
Materials and Methods
Inbred WF and WKy rats were obtained from Harlan Sprague-Dawley, Inc. (Indianapolis, IN) and fed Teklad lab blox chow and acidified water ad libitum. Rats were maintained in a 12-hour light/dark cycle in an Association for Assessment of Laboratory Animal Care-approved facility and all protocols were approved through the University of Wisconsin Medical School Animal Research Committee. Congenic lines were established and maintained as previously published (5) . Congenics are defined as genetic lines developed on a WF genome and carrying the selected WKy alleles shown in Fig. 1 . The congenic generation (number of backcrosses) used to determine each line phenotype and the approximate amount of unselected WKy sequence present at the respective line's generation are listed in Table 1 . Primer information for the markers listed on the y axis of Fig. 1 is available from the Rat Genome Database, 1 except for the following markers with the respective primer pair sequences listed here:
. gUwm40-18, 5V -GACTTAATGTGGGGAGTGAA and 5V -AGCACATATG-GAGGTTTGAC . gUwm45-5 , 5V -CTAGAAAGGTGCTTTGGTTG and 5V -TCAGCTT-CTCCTCCTTCC . gUwm50-22, 5V -TGAGACCTGGAACTTATTGG and 5V -CAGAGCCTAAGG-GATTCAG . bUwm26-2 , 5V -ACACTGAAGGTTGAGCTTGT and 5V -ACTCACCTC-TGTTCATCCTG . bUwm36-1 , 5V -CCTGTGATTCCAACTCTAGG and 5V -GATTCCT-CTGTTCTTCTGGA . bUwm32-4 , 5V -AGCAAGTTCTAGGACAACCA and 5V -CTGGGG-AGTTTTTCCTTATT.
To determine mammary carcinoma susceptibility phenotypes, female rats ages 50 to 55 days that were WKy homozygous, WKy/WF heterozygous, or WF homozygous at the selected congenic intervals were administered a single dose (65 mg/kg) of DMBA (ACROS Organics, Fisher Scientific, Pittsburgh, PA) in sesame oil by gastric intubation. Mammary carcinomas of >3 Â 3 mm were counted at 15 weeks after carcinogen administration. Mammary carcinoma multiplicity data were analyzed using the Kruskal-Wallis nonparametric test and ANOVA with the Sheffe multiple comparison procedure of StatView (SAS Institute, Inc., Cary, NC). In addition to their WKy/WF-heterozygous and WF-homozygous littermates, WKy-homozygous females were also compared with inbred WF females (parental recipient strain).
Phenotypic values for Mcs5 subloci combinations were predicted using the applicable additive, dominance, and interaction effects that were determined empirically using heterozygous and homozygous females from congenic lines and F 1 offspring of congenic line crosses. The mean mammary carcinomas per rat of the WF-homozygous genotype for each experiment was used as the baseline phenotype; thus, the genetic components are expressed relative to the WF phenotype (i.e., no WKy alleles at any of the Mcs loci). The one-sample t test function of StatView was used to compare mammary carcinoma multiplicity statistics to the predicted phenotypic values. The final predictive model for the WKy Mcs5 QTL mammary carcinoma multiplicity phenotype was determined to be:
where Mcs5 is the mammary carcinoma susceptibility/rat phenotype, l is the mean effect with no WKy alleles present at any of the Mcs loci (i.e., WF homozygous), A is the additive effect of the WKy allele relative to the WFhomozygous phenotype, D is the dominance deviation of the WKy allele relative to the additive genotypic value of the heterozygote, and I is the interaction between WKy alleles at Mcs5 subloci. The effects of WKy alleles on mammary carcinoma multiplicity were also estimated using the general linear model function with a Poisson regression in the R statistical computing environment (The R Foundation for Statistical Computing ). Data used were mammary carcinoma multiplicities from the congenic lines that contained Mcs5 loci and crosses of these lines (lines C, F, O, Q, Y, and OxY). Figure 1 illustrates the Mcs5 QTL region of rat chromosome 5 that was defined by statistical analysis of backcross data and further characterized by the congenic rat lines WF.WKy-D5Wox7/D5Uwm37 (line C) and WF.WKy-D5Rat26/D5Uwm42 (line D; refs. 4, 5) . Line C females with two WKy alleles at the Mcs5 locus (WKy homozygous) developed an average of 1.3 F 0.2 mammary carcinomas per rat (n = 43), which was less (P < 0.0001) than females that inherited two WF alleles at the Mcs5 locus (WF homozygous) and averaged 7.7 F 0.8 mammary carcinomas per rat (n = 28; Table 1 ). The objective of the work here was to fine map the Mcs5 locus in line C using recombinant congenic lines that carry shorter segments of the WKy chromosome 5 Mcs5 locus. Several WF.WKy-Mcs5-region recombinant congenic rat lines were bred that contained different segments of the WKy chromosome 5 candidate region (Fig. 1) . The recombinant congenic lines and the genetic markers that define their WKy intervals are defined as follows: line E, WF.WKy-gUwm47-10/D5Uwm37; line F, WF.WKy-gUwm40-18/AU048474; line G, WF.WKy-D5Wox8/gUwm41-6; line O, WF.WKy-gUwm40-18/gUwm45-5; line Q, WF.WKy-gUwm50-22/AU048474; line T, WF.WKy-bUwm26-2/bUwm36-1; and line Y, WF.WKy-bUwm32-4/D5Mit4.
Results and Discussion
As shown in Table 1 , WKy-homozygous females from line O averaged 4.0 F 0.4 mammary carcinomas per rat (n = 49), which was statistically different from the WF-homozygous littermates (P < 0.0001) and the WF parental strain (P < 0.0001). The WKy mammary cancer resistance allele in congenic line O spans a 4.5-Mb region from genetic markers gUwm40-18 to gUwm45-5. However, the candidate region defining the Mcs5a locus in this line is further delimited by the overlap of the proximal end of line O with the distal end of mammary carcinoma susceptible congenic line G. Line G females that are WKy homozygous averaged 8.9 F 0.5 mammary carcinomas per rat (n = 53), which was not statistically different from the WF parent strain or the line G WF-homozygous females that average 7.5 F 0.8 carcinomas per rat (n = 10; Table 1 ). Congenic line G is defined proximally by marker D5Wox8 and distally by gUwm41-6 ( Fig. 1) . Thus, the region of overlap with line O is between the distal and proximal ends of lines G and O, respectively. This overlap region is defined by the markers gUwm40-18 and gUwm41-6 and is not expected to contain Mcs5a susceptibility genes or elements. Taken together, Mcs5a is thus contained in the f1-Mb region between markers gUwm41-6 and gUwm45-5. The negative result obtained with line G also rules out the possibility that the proximal end of positive line C from markers D5Wox7 to gUwm41-6 contains independently acting Mcs5 subloci.
Distal to the Mcs5a locus on rat chromosome 5 is Mcs5b, defined by congenic line Q, which has an unexpected phenotype of increased mammary carcinoma susceptibility compared with WF-homozygous rats. As shown in Table 1 , line Q WKy-homozygous females averaged 11.6 F 0.6 mammary carcinomas per rat (n = 59). This was significantly higher (P < 0.01) than the WF-homozygous group that averaged 7.6 F 0.6 mammary carcinomas per rat (n = 30) and the WF parental strain (P < 0.0001). Distally, the Mcs5b locus is delimited by the overlap of line Q and congenic line T ( Fig. 1 ), which has a mammary carcinoma susceptibility phenotype similar to the WF inbred strain. Line T females that were WKy homozygous averaged 9.7 F 0.5 mammary carcinomas per rat (n = 34), which was not statistically different (P > 0.05) from the WF-homozygous females that averaged 8.5 F 0.7 carcinomas per rat (n = 21; Table 1 ) but was statistically different from the WKy-homozygous line Q females (P < 0.01). Congenic line T overlaps the distal end of line Q ( Fig. 1) , further narrowing the Mcs5b locus to the region spanned, minimally, by proximal marker gUwm50-22 and distal marker bUwm26-2. Thus, the Mcs5b locus maps to the f7.5-Mb region of rat chromosome 5.
Distally, the susceptible line T overlaps congenic line Y that contains the Mcs5c locus. In DMBA-induced mammary carcinogenesis experiments, WKy-homozygous females from line Y averaged 3.5 F 0.4 mammary carcinomas per rat (n = 30), which was a significant reduction in tumor multiplicity compared with the WFhomozygous females that averaged 9.6 F 1.1 mammary carcinomas per rat (n = 29; P < 0.0001) and the WF parental strain (P < 0.0001; Table 1 ). Congenic line E overlaps the distal end of line Y and was used to further define the Mcs5c locus because of its mammary carcinoma susceptibility phenotype. Line E females that were WKy homozygous for this region of rat chromosome 5 averaged 6.0 F 0.5 mammary carcinomas per rat (n = 47), which was not statistically different from the WF-homozygous or the inbred WF females that, respectively, averaged 7.7 F 0.8 and 6.4 F 0.6 mammary carcinomas per rat (n = 20 and n = 27). Considering the mammary carcinomaresistant phenotype of line Y and the susceptible phenotypes of overlapping lines E and T, the Mcs5c locus is defined by a f4.5-Mb region of rat chromosome 5 from bUwm36-1 to gUwm47-10.
To determine the effect of one WKy allele at each of the Mcs5 subloci, the phenotypes of heterozygous and homozygous rats were compared from each congenic line for which the WKy-homozygous phenotype deviated significantly (P < 0.05) from the WF susceptibility phenotype (Table 1) . Line O (Mcs5a) females with one WKy allele (WKy/WF) developed an average of 5.9 F 0.4 mammary carcinomas per rat (Table 1) , which was 66% of the average number of mammary carcinomas per rat that developed in the line-control littermates with two WF alleles (WF homozygous; Fig. 2 ) that averaged 8.9 F 0.8 mammary carcinomas per rat (P < 0.01). Line O heterozygous rats were also significantly different from the WKyhomozygous group that averaged 4.0 F 0.4 mammary carcinomas per rat (n = 49; P < 0.05). The observed mammary tumor multiplicity phenotype for line O heterozygous females, which was approximately intermediate (5.9 observed versus 6.5 midpoint) between the two homozygous phenotypic values (4.0 and 8.9), was not statistically different from the midpoint (P = 0.08), suggesting that no dominance exists with respect to the WKy and WF Mcs5a alleles.
Regarding the Mcs5b locus, one or two WKy copies resulted in 43% and 53% increases, respectively, in average mammary carcinomas per rat relative to the WF-homozygous genotype (Fig. 2) . The heterozygous group from line Q averaged 10.9 F 0.6 mammary carcinomas per rat (n = 49; Table 1 ). The heterozygous females were significantly different from WF-homozygous females that averaged 7.6 F 0.6 mammary carcinomas per rat (n = 30; P < 0.01); but not statistically different from the WKy-homozygous genotype, indicating that the Mcs5b WKy allele has some degree of dominance over the WF allele. The observed value (10.9 mammary carcinomas per rat) for the line Q heterozygous genotype was significantly different (P < 0.05) from the midpoint (9.6 mammary carcinomas per rat) between the two homozygous genotypes. This result indicates that the WKy Mcs5b allele has a dominance deviation of +1.3 mammary carcinomas per rat (10.9-9.6) with respect to the WF allele.
The line Y (Mcs5c) heterozygous group developed 64% of the number of mammary carcinomas per rat of the WF-homozygous littermate females (Fig. 2) , whereas the WKy-homozygous line Y (Mcs5c) females averaged 36% the number of mammary carcinomas relative to the WF-homozygous phenotype. Line Y heterozygous females averaged 6.1 F 0.6 mammary carcinomas per rat, which was significantly different from the WF-homozygous genotype (P < 0.01; Table 1 ). The WKy-homozygous and WKy/WF-heterozygous females from line Y were also significantly different (P < 0.05) from each other. The mammary carcinoma multiplicity phenotype observed for line Y heterozygous females (6.1 mammary carcinomas per rat) was not statistically different (P = 0.20) from the midpoint value (6.6 mammary carcinomas per rat) calculated from the two homozygous phenotypic values (3.5 and 9.6), indicating that no dominance exists with respect to the WKy and WF Mcs5c alleles.
Congenic line C heterozygous females, which had one WKy allele of each of the identified Mcs5 subloci, were tested for this study to determine if the resistance phenotype of the heterozygote was different from the WKy-homozygous phenotype. Line C heterozygous rats averaged 2.1 F 0.3 mammary carcinomas per rat (n = 43; Table 1 ). This was significantly different from the line C females that inherited only WF Mcs5 alleles (WF homozygous; P < 0.0001) but not different from the line C WKy-homozygous females (1.3 F 0.2 mammary carcinomas per rat; n = 43). Thus, the combined haploid effects of one copy of each of the ), the estimated additive genotypic value for the line C heterozygote relative to the WF-homozygous phenotype (7.7 mammary carcinomas per rat) is 5.9 mammary carcinomas per rat. This value is calculated using the statistics from Table 1 {[7.7 + (7.7 Â À27%) + (7.7 Â 26%) + (7.7 Â À31%)] + (5.2 Â 14%)}. However, the observed genotypic value for the heterozygote (line C) is 2.1 F 0.3 mammary carcinomas per rat (Table 1) , which is statistically different from the 5.9 estimate (P < 0.0001).
Assuming that Mcs5a, Mcs5b, and Mcs5c are distinct individual loci, we evaluate the potential nonadditive interactions among them. To determine if one of the Mcs5 subloci conferring resistance to the development of mammary carcinomas showed an epistatic interaction with the Mcs5b locus, we tested line F (Fig. 1) Fig. 2 may be experimentally indistinguishable from the WF phenotype. However, the mammary carcinoma multiplicity of line F heterozygous females was statistically different (P < 0.05) from that of the WF-homozygous females (Table 1) ; but, contrary to the predicted increase based on the additive and dominance components of Mcs5a + Mcs5b, the WKy allele in line F conferred a decreased susceptibility compared with the WF genotype. WKy-homozygous females from line F also had a decreased susceptibility phenotype. They developed 4.9 F 0.3 mammary carcinomas per rat (n = 89), which was significantly different (P < 0.001) from the WF-homozygous females from line F that developed 7.5 F 0.5 mammary carcinomas per rat (n = 50; The resulting heterozygous females from this cross had an average of 3.4 F 0.4 mammary carcinomas per rat (n = 36), significantly less (P < 0.0001) than the average of 9.7 F 0.8 mammary carcinomas per rat (n = 13) for the WF-homozygous congenic females (Table 1) correspond to 4.1 mammary carcinomas per rat (9.7-2.6-3.0; Fig. 2 ). This would be 42% of the number of mammary carcinomas per rat compared with the WF-homozygous genotype (4.1 versus 9.7; Fig. 2 (Fig. 2) . These relative mammary carcinoma multiplicity phenotypes for the two groups were not statistically different (P = 0.09). Therefore, the strong phenotype of line C (Mcs5c), where the heterozygote developed 27% of the number of mammary carcinomas per rat compared with the WF-homozygous genotype, may be explained by the additive, dominance, and interaction effects of the To further test the hypothesis that Mcs5a interacts with Mcs5b and Mcs5c, we used a general linear model that incorporated a Poisson regression analysis to estimate the effect of WKy alleles on mammary carcinoma multiplicity. The estimated fold change in mammary carcinoma multiplicity for the main and interaction effects are shown in Table 2 . As expected, the main effects for each Mcs5 sublocus were significant (P < 0.0001). The magnitude of the fold changes in mammary carcinoma susceptibilities with one versus two WKy alleles at Mcs5a and Mcs5c loci were additive, whereas the WKy allele at the Mcs5b locus exhibited a degree of dominance over the WF allele. Furthermore, the fold changes in mammary carcinoma multiplicity phenotype estimated by the model for one WKy allele at each of the Mcs5 subloci were similar to the additive effects calculated in Table 1 The current data support the existence of at least three distinct subloci within the Mcs5 QTL. It is possible, however, that one or more of these subloci may harbor multiple genetic elements that modulate susceptibility to mammary cancer through independent or interactive activities. In spite of this, the three currently identified subloci and their likely epistatic interactions clearly classify the Mcs5 QTL as complex. Interestingly, the only other rat mammary carcinoma susceptibility QTL that has been fine mapped, Mcs1, has also been shown to have at least three subloci that modulate risk (7) . In addressing the complexity of the Mcs1 locus, we postulated that because many mammary cancer modifiers are likely to have relatively low penetrance, especially as heterozygous alleles, QTL mapping in a backcross study might most readily detect areas of the genome that harbor multiple risk modifiers in a limited genomic interval. Furthermore, we surmised that these loci in close proximity to each other should all act in a similar direction to increase or decrease risk.
Mcs5 seems more complex than Mcs1 in that, contrary to the above assumption, the subloci in Mcs5 do not act in the same direction. Mcs5a and Mcs5c act to decrease risk, whereas Mcs5b acts to increase risk. If these three subloci acted solely in an independent manner (i.e., additive), it is unlikely that the Mcs5 QTL would have been detected in our backcross linkage study. The Mcs5 QTL was likely discovered, because Mcs5a in its WKy haplotype epistatically minimized the risk enhancement activity of Mcs5b. Thus, the linkage study identified the Mcs5 QTL as its effect was similar to the sum of Mcs5a and Mcs5c. Most linkage studies would lack the resolution to individually identify these three Mcs5 subloci due to their close proximity. The proximity of subloci within both Mcs5 and Mcs1 raise the question of why this clustering occurs. Two extreme possibilities exist. The first would suggest that there are thousands of mammary cancer modifier genetic elements randomly dispersed in the genome, and the current experimental power in most linkage modifier mapping experiments define a subset of these, which lie in close proximity. The second is compatible with a more limited number of modifier genes that are located in proximity due to functional constraints or their evolutionary origins from a single ancestral gene. As we identify and functionally characterize distinct genetic elements within these loci, we will be better able to address these and other possibilities.
The work reported here furthers our investigations into the comparative genetics of breast cancer and shows the complexity of the multigenic etiologic components of breast cancer. This approach identifies novel susceptibility loci that, when translated to humans, may provide an unbiased selection method of novel candidate loci for evaluation in breast cancer case-control association studies. , the interaction between loci with one WKy allele at each locus i and j; and I aMcs5iaMcs5j , the interaction between loci with two WKy alleles at each locus i and j.
